FTC Health Care Chief: $1.2B Cephalon Deal A Strong Warning
Cephalon Inc.'s promise to settle patent litigation without using side deals to get reverse payments as part of a $1.2 billion agreement with the Federal Trade Commission sends a "strong and...To view the full article, register now.
Already a subscriber? Click here to view full article